| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/nar/UrsuHKBYMNO17 |
| P356 | DOI | 10.1093/NAR/GKW993 |
| P932 | PMC publication ID | 5210665 |
| P698 | PubMed publication ID | 27789690 |
| P50 | author | Cristian G. Bologa | Q38323657 |
| Tudor I Oprea | Q38323677 | ||
| P2093 | author name string | Jeremy J Yang | |
| Stuart J Nelson | |||
| Oleg Ursu | |||
| Jayme Holmes | |||
| Jeffrey Knockel | |||
| Stephen L Mathias | |||
| P2860 | cites work | InChI - the worldwide chemical structure identifier standard | Q21030547 |
| Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data | Q23781420 | ||
| DrugBank 4.0: shedding new light on drug metabolism | Q24568341 | ||
| Computational and Practical Aspects of Drug Repositioning | Q26799146 | ||
| The ChEMBL bioactivity database: an update | Q27144224 | ||
| Calculating log Poct from structures | Q63367539 | ||
| SNOMED-CT: The advanced terminology and coding system for eHealth | Q79345011 | ||
| Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited | Q27783587 | ||
| Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
| IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data | Q27902312 | ||
| Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action | Q28564857 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands | Q28603128 | ||
| The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013 | Q28710191 | ||
| KEGG for integration and interpretation of large-scale molecular data sets | Q29547277 | ||
| The Unified Medical Language System (UMLS): integrating biomedical terminology | Q29547612 | ||
| The SIDER database of drugs and side effects | Q30002337 | ||
| Property distribution of drug-related chemical databases. | Q30855791 | ||
| Development of the Logical Observation Identifier Names and Codes (LOINC) Vocabulary | Q33950841 | ||
| The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics | Q34992596 | ||
| Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer-Aided Drug Repurposing. | Q35694643 | ||
| Drug Repurposing from an Academic Perspective | Q35774211 | ||
| SuperTarget goes quantitative: update on drug-target interactions | Q38499993 | ||
| A comprehensive map of molecular drug targets. | Q39026969 | ||
| SuperDrug: a conformational drug database | Q43567224 | ||
| e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. | Q47993030 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | D1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DrugCentral | Q27697289 |
| P304 | page(s) | D932-D939 | |
| P577 | publication date | 2016-10-26 | |
| P1433 | published in | Nucleic Acids Research | Q135122 |
| P1476 | title | DrugCentral: online drug compendium | |
| P478 | volume | 45 |
| Q92219098 | A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine |
| Q90225976 | A Free Web-Based Protocol to Assist Structure-Based Virtual Screening Experiments |
| Q92277777 | A Web Tool for Ranking Candidate Drugs Against a Selected Disease Based on a Combination of Functional and Structural Criteria |
| Q96768561 | A comprehensive integrated drug similarity resource for in-silico drug repositioning and beyond |
| Q39026969 | A comprehensive map of molecular drug targets. |
| Q90648694 | A network pharmacology-based approach to analyse potential targets of traditional herbal formulas: An example of Yu Ping Feng decoction |
| Q91329651 | A network-based approach to identify deregulated pathways and drug effects in metabolic syndrome |
| Q102373171 | A review of computational drug repositioning: strategies, approaches, opportunities, challenges, and directions |
| Q37698356 | A standard database for drug repositioning. |
| Q89457556 | A systematic assessment of the availability and clinical drug information coverage of machine-readable clinical drug data sources for building knowledge translation products |
| Q90669183 | Adsorptive interaction of peroxymonosulfate with graphene and catalytic assessment via non-radical pathway for the removal of aqueous pharmaceuticals |
| Q91251572 | Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases |
| Q92614485 | CDEK: Clinical Drug Experience Knowledgebase |
| Q109116592 | Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing |
| Q55717464 | Changing Trends in Computational Drug Repositioning. |
| Q93101690 | Comparison of 71 bipolar disorder pharmacotherapies for kidney disorder risk: The potential hazards of polypharmacy |
| Q88532577 | Complex network theory for the identification and assessment of candidate protein targets |
| Q94554231 | Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors |
| Q57170230 | Computational resources associating diseases with genotypes, phenotypes and exposures |
| Q57283582 | Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation |
| Q92212072 | DDI-PULearn: a positive-unlabeled learning method for large-scale prediction of drug-drug interactions |
| Q88061339 | Data Sets Representative of the Structures and Experimental Properties of FDA-Approved Drugs |
| Q100529876 | Disentangling the Therapeutic Tactics in GBM: From Bench to Bedside and Beyond |
| Q52608766 | Drug Repositioning in Glioblastoma: A Pathway Perspective |
| Q99709300 | Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak |
| Q89994316 | Drug Repurposing Using Deep Embeddings of Gene Expression Profiles |
| Q46264677 | Drug target ontology to classify and integrate drug discovery data |
| Q58106086 | DrugCentral 2018: an update |
| Q101339870 | DrugCentral 2021 supports drug discovery and repositioning |
| Q108127179 | Drugmonizome and Drugmonizome-ML: integration and abstraction of small molecule attributes for drug enrichment analysis and machine learning |
| Q57191805 | Editorial: Drug Repositioning: Current Advances and Future Perspectives |
| Q92040294 | Evaluating the consistency of large-scale pharmacogenomic studies |
| Q47893147 | Evidence-Based Precision Oncology with the Cancer Targetome. |
| Q93103054 | Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs |
| Q64987443 | Exploiting semantic patterns over biomedical knowledge graphs for predicting treatment and causative relations. |
| Q91596051 | Exploring the dark genome: implications for precision medicine |
| Q45982826 | Formalizing drug indications on the road to therapeutic intent. |
| Q64113830 | Free Accessible Databases as a Source of Information about Food Components and Other Compounds with Anticancer Activity⁻Brief Review |
| Q92240403 | GUILDify v2.0: A Tool to Identify Molecular Networks Underlying Human Diseases, Their Comorbidities and Their Druggable Targets |
| Q61455067 | GenCoNet – A Graph Database for the Analysis of Comorbidities by Gene Networks |
| Q101562822 | High intensity interval training exercise-induced physiological changes and their potential influence on metabolic syndrome clinical biomarkers: a meta-analysis |
| Q100995869 | High-throughput virtual screening of drug databanks for potential inhibitors of SARS-CoV-2 spike glycoprotein |
| Q92219084 | How to Prepare a Compound Collection Prior to Virtual Screening |
| Q91595155 | HyperFoods: Machine intelligent mapping of cancer-beating molecules in foods |
| Q96950052 | Identification of a druggable binding pocket in the spike protein reveals a key site for existing drugs potentially capable of combating Covid-19 infectivity |
| Q93121098 | Identification of metabolites identical and similar to drugs as candidates for metabolic engineering |
| Q92872580 | Identification of novel analgesics through a drug repurposing strategy |
| Q93061511 | In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
| Q98157033 | In silico Drug Repurposing for COVID-19: Targeting SARS-CoV-2 Proteins through Docking and Consensus Ranking |
| Q112691990 | InContext: curation of medical context for drug indications |
| Q38687421 | Information Retrieval and Text Mining Technologies for Chemistry. |
| Q98665501 | KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response |
| Q102043840 | KG-COVID-19: a framework to produce customized knowledge graphs for COVID-19 response |
| Q112130996 | NCATS Inxight Drugs: a comprehensive and curated portal for translational research |
| Q57491987 | Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response |
| Q57816959 | Network-Based Methods for Prediction of Drug-Target Interactions |
| Q92064066 | Non-Negative Matrix Factorization for Drug Repositioning: Experiments with the repoDB Dataset |
| Q98901564 | Off-patent drug repositioning |
| Q58767948 | Online structure-based screening of purchasable approved drugs and natural compounds: retrospective examples of drug repositioning on cancer targets |
| Q57832760 | Open chemoinformatic resources to explore the structure, properties and chemical space of molecules |
| Q88446699 | Pan-assay interference compounds (PAINS) that may not be too painful for chemical biology projects |
| Q37556791 | Pharos: Collating protein information to shed light on the druggable genome |
| Q60923441 | Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases |
| Q45948712 | Protein biomarker druggability profiling. |
| Q57814810 | Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease |
| Q91461049 | ROBOKOP KG and KGB: Integrated Knowledge Graphs from Federated Sources |
| Q90707908 | Repurposing of known drugs for leishmaniasis treatment using bioinformatic predictions, in vitro validations and pharmacokinetic simulations |
| Q98392875 | Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies |
| Q47368493 | Serine protease inhibitors to treat inflammation: a patent review (2011-2016). |
| Q47142191 | SuperDRUG2: a one stop resource for approved/marketed drugs |
| Q111149881 | Supervised learning with word embeddings derived from PubMed captures latent knowledge about protein kinases and cancer |
| Q58079602 | Survey of Similarity-based Prediction of Drug-protein Interactions |
| Q55345467 | Sustainable data and metadata management at the BD2K-LINCS Data Coordination and Integration Center. |
| Q42255083 | Systematic integration of biomedical knowledge prioritizes drugs for repurposing |
| Q102144641 | The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer |
| Q47139831 | The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY. |
| Q92938700 | The human endogenous metabolome as a pharmacology baseline for drug discovery |
| Q52598358 | The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity. |
| Q47116549 | Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics |
| Q91910024 | Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network |
| Q97542250 | Toward heterogeneous information fusion: bipartite graph convolutional networks for in silico drug repurposing |
| Q94335553 | Towards reproducible computational drug discovery |
| Q52689109 | Unexplored therapeutic opportunities in the human genome. |
| Q104489331 | Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19 |
| Q92355875 | Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz |
| Q89464402 | Web-based tools for drug repurposing: successful examples of collaborative research |
| Q104213849 | Wikidata as a FAIR knowledge graph for the life sciences |
| Q87830400 | Wikidata as a knowledge graph for the life sciences |
Search more.